While much of Valneva's focus these days is centered on its landmark vaccine for chikungunya virus, the French immunization specialist's catalog of older shots continues to serve up fresh governmen | ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the signing of a new $32.8 million contract with the United States (U.S.) Department of Defense (DoD) for ...

A RESIDENT has expressed their concern at the difficulty and confusion surrounding access to a potentially life-saving vaccine. Offering protection against the Japanese Encephalitis Virus (JEV), a ...

A study was conducted to assess the safety and tolerability of the tetravalent live-attenuated dengue vaccine Qdenga®, which received marketing approval in Germany in 2022. The study evaluated vaccine ...

In a report released on January 31, Justine Telliez from Kepler Capital maintained a Buy rating on Valneva (0OB3 – Research Report), with a ...

Kennedy is denying the facts – that vaccines are one of the most powerful interventions in history. That they have saved ...

At Nong Samor Sub-district Health Promoting Hospital, East Pattaya, parents brought their children, aged newborn to four ...

Nov. 3, 2023 — Researchers have pioneered a novel treatment for the most common autoimmune encephalitis. By reprogramming white blood cells to target and eliminate ... The Quail Could Be the ...

Valneva (VALN) stock gained as its chikungunya vaccine receives marketing authorization in the U.K., expanding the single-dose shot's global reach. Read more here.

Hundreds of people gathered Sunday at a Buddhist temple in downtown Tokyo, eagerly stretching their hands to catch the dried ...